Smith & Wesson Brands (SWBI) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
6 Aug, 2026Executive summary
Annual meeting scheduled for September 15, 2026, to be held virtually; record date is July 24, 2026.
Key accomplishments in fiscal 2026: net sales of $523.8M (up 10.4%), $114.2M cash from operations, $23.2M in dividends, $60M debt repayment, and opening of Smith & Wesson Academy.
Board recommends voting FOR all proposals: election of directors, advisory vote on executive compensation, and ratification of KPMG LLP as auditor.
Voting matters and shareholder proposals
Shareholders will vote on: (1) election of six directors, (2) advisory say-on-pay for executive compensation, (3) ratification of KPMG LLP as independent auditor for fiscal 2027.
Board recommends FOR all director nominees and proposals.
Shareholder proposals or director nominations for 2027 must be submitted between May 18 and June 17, 2027.
Board of directors and corporate governance
Board consists of six nominees, five of whom are independent; two-thirds joined since 2018.
Committees: Audit, Compensation, Nominations and Corporate Governance (NCG); Sustainability Committee dissolved April 30, 2026.
Board refreshment emphasized; no mandatory retirement age or term limits.
Proxy access allows stockholders (3%+ ownership for 3 years) to nominate up to 20% of the board.
Directors may not serve on more than three other public company boards.
Latest events from Smith & Wesson Brands
- Virtual annual meeting to vote on directors, executive pay, and auditor ratification.SWBI
Proxy filing6 Aug 2026 - Achieved double-digit growth, expanded product lines, and strengthened market leadership.SWBI
Investor Day 2026 presentation19 Jul 2026 - Strong Q4 and FY26 results, with robust growth, margin gains, and positive outlook for FY27.SWBI
Q4 202617 Jun 2026 - Q3 net sales up 17.1% to $135.7M, with higher margins and strong Q4 outlook.SWBI
Q3 20265 Mar 2026 - Double-digit growth in revenue and net income, with 2025 outlook for continued gains and higher dividends.SWBI
Q4 20243 Feb 2026 - Q1 sales fell 22.7%, but new products and margin gains support a positive full-year outlook.SWBI
Q1 202522 Jan 2026 - Board re-elections, executive pay approval, and strong financial growth highlighted the meeting.SWBI
AGM 202420 Jan 2026 - Q2 sales up 3.8% to $129.7M, but guidance cut as inflation softens demand and margins.SWBI
Q2 202511 Jan 2026 - Q3 sales fell 15.7% as new products drove 41% of revenue, but margins and sales remain pressured.SWBI
Q3 202527 Dec 2025